Literature DB >> 17917891

UC blood-derived mesenchymal stromal cells: an overview.

A Flynn1, F Barry, T O'Brien.   

Abstract

The UC is a readily available source of blood that may be used for analysis and treatment. Some authors suggest that within the UC blood (UCB) are cells with potential for differentiation down mesenchymal lineages. Isolation and characterization of these cells has been accomplished in some centers. Differentiation of these cells down multiple lineages has been documented. Surface marker expression and gene expression profiling has been performed, and mesenchymal stromal cells (MSC) from BM and adipose tissue have been compared with those derived from UCB. The use of UCB-derived stem cells has been investigated in pre-clinical studies. As this field is rapidly advancing, this review summarizes the current state of our knowledge of MSC derived from UCB.

Mesh:

Substances:

Year:  2007        PMID: 17917891     DOI: 10.1080/14653240701584578

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  46 in total

1.  A dose-dependent function of follicular fluid on the proliferation and differentiation of umbilical cord mesenchymal stem cells (MSCs) of goat.

Authors:  Pubin Qiu; Yaofu Bai; Chao Liu; Xin He; Hui Cao; Mingzhao Li; Haijing Zhu; Jinlian Hua
Journal:  Histochem Cell Biol       Date:  2012-06-10       Impact factor: 4.304

2.  GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells.

Authors:  Hye Jin Jin; Hae Yun Nam; Yun Kyong Bae; Soo Yeon Kim; I Rang Im; Wonil Oh; Yoon Sun Yang; Soo Jin Choi; Seong Who Kim
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

3.  Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue.

Authors:  Leon J Nesti; Wesley M Jackson; Rabie M Shanti; Steven M Koehler; Amber B Aragon; James R Bailey; Michael K Sracic; Brett A Freedman; Jeffrey R Giuliani; Rocky S Tuan
Journal:  J Bone Joint Surg Am       Date:  2008-11       Impact factor: 5.284

Review 4.  Mesenchymal stem cells in joint disease and repair.

Authors:  Frank Barry; Mary Murphy
Journal:  Nat Rev Rheumatol       Date:  2013-07-23       Impact factor: 20.543

5.  Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Authors:  Ioannis Christodoulou; Maria Goulielmaki; Marina Devetzi; Mihalis Panagiotidis; Georgios Koliakos; Vassilis Zoumpourlis
Journal:  Stem Cell Res Ther       Date:  2018-12-07       Impact factor: 6.832

Review 6.  Repairing neural injuries using human umbilical cord blood.

Authors:  Tao Sun; Quan-Hong Ma
Journal:  Mol Neurobiol       Date:  2012-12-30       Impact factor: 5.590

7.  Dissection of the cord blood stromal component reveals predictive parameters for culture outcome.

Authors:  Mario Barilani; Cristiana Lavazza; Mariele Viganò; Tiziana Montemurro; Valentina Boldrin; Valentina Parazzi; Elisa Montelatici; Mariacristina Crosti; Monica Moro; Rosaria Giordano; Lorenza Lazzari
Journal:  Stem Cells Dev       Date:  2015-01-01       Impact factor: 3.272

8.  Advancing biomaterials of human origin for tissue engineering.

Authors:  Fa-Ming Chen; Xiaohua Liu
Journal:  Prog Polym Sci       Date:  2015-03-28       Impact factor: 29.190

Review 9.  Clinical Translation of Mesenchymal Stromal Cell Therapies in Nephrology.

Authors:  Norberto Perico; Federica Casiraghi; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2017-11-30       Impact factor: 10.121

10.  Mesenchymal stem-like cells isolated from human esophageal carcinoma and adjacent non-cancerous tissues.

Authors:  Jiabo Hu; Zhongwei Zhou; Shunbin Shi; Xiaozhong Zhu; Xiaohui Wang; Wei Zhang; Sanqiang Hu; Hui Qian; Wenrong Xu
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.